Publication | Closed Access

Effects of CS-514, a New Inhibitor of HMG CoA Reductase, on Plasma Lipids, Lipoproteins and Apoproteins in Patients with Primary Hypercholesterolemia

Metabolic SyndromePrimary HypercholesterolemiaLipid DisorderOxysterolCardiovascular DiseaseBiochemistryMedicineNew InhibitorHematologyHyperlipidemiaLipoprotein MetabolismHmg Coa ReductasePharmacologyAtherosclerosisDyslipidemiaOxidative StressHealth Sciences